Pfizer oral antiviral safe and effective against SARS-CoV-2

Medical News Today - 08 Nov 2021
Pfizer has recently published a paper demonstrating that its candidate antiviral drug is safe and has antiviral effects against SARS-CoV-2.

Pfizer focuses on long COVID in latest 'Dear Scientist' video

FiercePharma - 17 Apr 2024
Pfizer focuses on long COVID in latest 'Dear Scientist' video ...

An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA ...

Cureus - 17 Apr 2024
An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA ... ...

Tackling Antibiotic Resistance

Pfizer - 10 Apr 2024
Tackling Antibiotic Resistance ...

Pfizer Inc. stock underperforms Wednesday when compared to competitors

MarketWatch - 17 Apr 2024
Pfizer Inc. stock underperforms Wednesday when compared to competitors ...

Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space

BioSpace - 17 Apr 2024
Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space ...

Connect uncouples from Pfizer by scrapping eczema pact

Fierce Biotech - 17 Apr 2024
Connect uncouples from Pfizer by scrapping eczema pact ...

Peninsula VC adds more than $100 million, brings on former Pfizer exec as partner - San Francisco Business Times

The Business Journals - 17 Apr 2024
Peninsula VC adds more than $100 million, brings on former Pfizer exec as partner - San Francisco Business Times ...

Pfizer wins pause on Moderna's COVID-19 patent lawsuit

Reuters - 12 Apr 2024
Pfizer wins pause on Moderna's COVID-19 patent lawsuit ...

Is Pfizer Stock a Buy?

Yahoo Finance - 15 Apr 2024
Is Pfizer Stock a Buy? ...

Like Pfizer and BioNTech, Moderna scales back its African ambitions

The Africa Report - 15 Apr 2024
Like Pfizer and BioNTech, Moderna scales back its African ambitions ...

How Pfizer Completely Dodged the Corporate Income Tax

Jacobin magazine - 12 Apr 2024
How Pfizer Completely Dodged the Corporate Income Tax ...

Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

CNBC - 09 Apr 2024
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use ...

Pfizer accused of 'bringing discredit' on industry with 'unnecessary' vaccine tweet

BioPharma-Reporter.com - 09 Apr 2024
Pfizer accused of 'bringing discredit' on industry with 'unnecessary' vaccine tweet ...

FDA may authorize Pfizer booster shots for all adults this week

AOL - 18 Apr 2024
FDA may authorize Pfizer booster shots for all adults this week ...

Biopharma Layoff Tracker 2024: Fujifilm, Genentech, Sanofi and More Cut Staff

BioSpace - 17 Apr 2024
Biopharma Layoff Tracker 2024: Fujifilm, Genentech, Sanofi and More Cut Staff ...

Pfizer’s year in review

Pfizer - 08 Mar 2024
Pfizer’s year in review ...

Canaan hires Pfizer executive, reels in $100M for biotech investing

Yahoo Finance - 17 Apr 2024
Canaan hires Pfizer executive, reels in $100M for biotech investing ...

Pfizer, BioNTech win pause in patent infringement case from rival Moderna

FiercePharma - 15 Apr 2024
Pfizer, BioNTech win pause in patent infringement case from rival Moderna ...

Canaan Secures More Than $100M in New Biopharma Funding, Adds Former Pfizer Executive

BioSpace - 17 Apr 2024
Canaan Secures More Than $100M in New Biopharma Funding, Adds Former Pfizer Executive ...

Pfizer